Medicine & TechnologyMontefiore Health System and Albert Einstein College of Medicine have begun with ACTT 2, a clinical trial using the drug combination remdesivir and baricitinib to treat patients with COVID-19. Researchers are hoping the new drug combo would reduce COVID-19-related inflammation and provide better recovery outcomes for coronavirus patients.
According to a recent study, the lesser the number of hours a child spends sleeping, the higher are the odds that he or she will become obese at a later age.